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ABSTRACT 
Introduction 
We investigated socioeconomic disparities and the role of the main prognostic factors in 
receiving major surgical treatment in lung cancer patients in England. 
Methods 
Our study comprised of 31351 patients diagnosed with Non-Small Cell Lung Cancer in England 
in 2012. Data from the national population-based cancer registry were linked to Hospital 
Episode Statistics and National Lung Cancer Audit data to obtain information on stage, 
performance status and comorbidities, and to identify patients receiving major surgical 
treatment. To describe the association between prognostic factors and surgery, we performed 
two different analyses: one using multivariable logistic regression, and one estimating cause-
specific hazards for death and surgery. In both analyses, we used multiple imputation to deal 
with missing data.  
Results 
We showed strong evidence that the comorbidities “congestive heart failure”, “cerebrovascular 
disease” and “chronic obstructive pulmonary disease” reduced the receipt of surgery in early-
stage patients. We also observed gender differences and substantial age differences in the 
receipt of surgery. Despite accounting for sex, age at diagnosis, comorbidities, stage at 
diagnosis, performance status and indication of having had a PET-CT scan, the socioeconomic 
differences persisted in both analyses: more deprived people had lower odds and lower rates 
of receiving surgery in early-stage lung cancer.  
Discussion 
Comorbidities play an important role in whether patients undergo surgery, but do not 
completely explain the socioeconomic difference observed in early stage patients. Future work 
investigating access to and distance from specialist hospitals, as well as patient perceptions and 
patient choice in receiving surgery, could help disentangle these persistent socioeconomic 
inequalities. 
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Short summary ‘box’  
 What is the key question? 
What is the association between specific comorbid conditions and the receipt of major surgical 
treatment in Non-Small Cell Lung Cancer (NSCLC) patients, and does it explain socio-economic 
inequalities in the receipt of treatment? 
 What is the bottom line? 
We showed strong evidence that (i) the comorbidities “congestive heart failure”, 
“cerebrovascular disease” and “chronic obstructive pulmonary disease” reduced the rate of 
surgery in early stage NSCLC patients, and (ii), after adjusting for covariates such as age, stage 
and performance status, socio-economic inequalities in receiving surgical treatment remain.  
 Why read on? 
Using population-based data, we quantified the association between specific comorbid 
conditions and the receipt of surgery, and showed that socio-economic inequalities in receiving 
major surgical treatment persist, even after accounting for the main prognostic factors (stage, 
performance status, specific comorbid conditions). 
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INTRODUCTION 
Lung cancer is the leading cause of cancer death in the United-Kingdom for both men and 
women: in 2014, more than 19000 deaths were observed in men and over 16000 in women, 
corresponding to age-standardised mortality rates of 89.69 and 60.52 per 100 000 person-
years, respectively.1 Despite encouraging decreasing age-standardised incidence in lung 
cancer,1 it remains a major public health issue given its poor prognosis; for patients diagnosed 
in England between 2010 and 2014, the one-year age-standardised net survival probability was 
estimated at 34% in men and 40% in women, those figures being 11% and 16% at 5 years.2 
Different studies have reported socio-economic inequalities, with a consistently lower survival 
for the more deprived patients.3-5 Disentangling the reasons behind these socioeconomic 
inequalities remains a topic of active research. One aspect to consider is any variation in patient 
characteristics between socio-economic groups. For example, studies that have examined the 
prevalence of comorbidity according to socio-economic group found that while comorbidity, or 
indeed multi-morbidity, was most prevalent in the elderly, it was also found in younger patients 
of lower socio-economic status.6 7 Moreover, some authors have suggested that variations in 
surgical resection rates and more generally in access to treatment could partly explain those 
inequalities.8-12 Understanding which factors are associated with the probability to receive 
major surgical treatment could help further improve the surgical resection rate, and thus lung 
cancer survival.8 In addition to the central role of tumour stage at diagnosis, the role of 
comorbidities is often studied using the summarised Charlson score.9-11 Thus, the question 
regarding the association between specific individual comorbid conditions and the probability 
to receive major surgery remains unresolved. We hypothesize that patients with comorbidities 
have lower probability of receiving surgery than patients without comorbidities. Conversely, we 
hypothesize that patients diagnosed with an early-stage tumour and whose health status is 
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good should be very likely to receive a surgical treatment with curative intent. Moreover, 
controlling for these specific comorbidities will allow assessment of whether the association 
between socioeconomic deprivation and treatment remains.  
We aim here to quantify the association between patient and tumour factors and the 
probability to receive major surgical treatment for patients diagnosed with Non-Small Cell Lung 
Cancer (NSCLC) in England in 2012, with a particular emphasis on the roles played by specific 
comorbid conditions and deprivation.  
 
METHODS 
Data 
Data were obtained from the National Cancer Registry at the Office for National Statistics13 for 
all adults (aged 15-99) diagnosed with a first primary malignant NSCLC (all ICD-O-3 morphology 
codes except those between 8041 and 8045, behaviour /3) in 2012 in England. Patients 
diagnosed with a lung cancer for which the morphology was malignant neoplasm Not Otherwise 
Specified (NOS) or Epithelial neoplasms NOS, were also included. All patients have been 
followed-up until the 31 December 2015 by the National Health Service Central Register, to 
update each patient’s vital status (alive, emigrated, dead or not traced). Data were further 
linked to the National Lung Cancer Audit (NLCA) data,14 using successively different 
combinations of patient identifier variables to ensure successful matching of same patients in 
the two datasets.15 The NLCA data captured information on several tumour and patient-related 
factors, such as (i) the tumour’s T, N, M (coding the size, the node and the metastasis 
components of stage, respectively), (ii) the patient’s performance status (PS), (iii) whether a 
PET-CT scan was performed (yes/no) and (iv) the surgical procedure undertaken with the 
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intention of curing the patient.14 PET-CT scan is recommended prior to surgery as it provides 
more accurate staging information, in particular detecting metastatic disease unidentified by 
other imaging investigations. We applied a previously developed algorithm to derive for each 
tumour a summarised 4-category stage at diagnosis variable using information from the NLCA 
in the first instance, and from the national cancer registry data if no information were present 
in the NLCA data.16 
For each NSCLC patient, we used the inpatient, outpatient, and Accident & Emergency Hospital 
Episode Statistics (HES) datasets to derive prevalence indicators of the 17 comorbid conditions 
of the Charlson Comorbidity Index, in addition to obesity.17 We focused on comorbidities that 
would influence fitness to undergo major surgery, namely myocardial infarction, congestive 
heart failure, peripheral vascular disease, cerebrovascular disease and chronic obstructive 
pulmonary disease (COPD).18 To retrieve information on comorbidity, we used a 6-year window 
up to 6 months before diagnosis, checking the diagnostic fields of the HES data to identify 
whether any of the aforementioned comorbidities had been recorded during this period.17 
The primary source of information for the major surgical treatment was the NLCA data, 
supplemented with information from the HES data where the former was unavailable. In both 
datasets, information on surgery (with the corresponding date) was recorded using the Office 
of Population Censuses and Surveys (OPCS) Classification of Interventions and Procedures 
(fourth version, ‘OPCS-4’).19 We pre-set a time window of 30 days before diagnosis and 180 
days after diagnosis to identify the first major surgical treatment received for each patient. The 
categorisation of surgery as ‘major’ was made according to the OPCS-4 codes recorded for the 
procedure, and was based on definitions of “surgery with curative intent” devised from 
extensive input from clinicians and oncologists and endorsed by the Site-Specific Clinical 
Reference Groups of the National Cancer Intelligence Network (Appendix 1).20 Where patients 
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had surgery before the recorded cancer diagnosis date, we recoded their time from diagnosis 
to surgery as 1 day for the time-to-event analysis (see Analysis section). 
We measured deprivation using the Income Domain from the 2010 England Indices of Multiple 
Deprivation (IMD) defined at the Lower Super Output Area level (average population of 
1,500).21 The Income Domain score is a combination of five indicators, and it measures the 
proportion of the population in an area experiencing deprivation related to low income. It 
ranges from 0 to 77%,21 (i.e. the higher the more deprived, see figure S2 in the appendix) and 
is named “deprivation score” hereafter. More details on the different deprivation measures and 
the way they are calculated could be found here 
(https://www.gov.uk/government/statistics/english-indices-of-deprivation-2010). 
 
Analysis 
The studied prognosis factors were sex, age at diagnosis, deprivation score, PS, stage at 
diagnosis, a binary variable indicating if a PET/PET-CT scan was performed, and five binary 
variables indicating the presence of specific comorbid conditions.  
We performed two types of analysis to describe the receipt of surgery while controlling for the 
prognostic factors. Firstly, we used a logistic regression model with major surgery (yes/no) as 
the outcome (Analysis 1). However, some patients may have died before having had a chance 
to receive surgery. Secondly, we modelled the two cause-specific hazards (i.e. one for surgery 
and one for death) using the semi-parametric Cox model (Analysis 2). We analysed the first 
event with the corresponding time-to-event, thus accounting for the competing risk of death:22 
patients who died without receiving surgery were censored for the surgery-specific rate. 
Conversely, patients who received surgery were censored at their time of surgery when 
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estimating the death-specific rate. As the time window for the surgery went up to a maximum 
of 180 days, patients alive without surgery after 180 days were censored at that time. 
In each analysis, the predictors were defined as follows: for the continuous variables age at 
diagnosis and deprivation score, we assumed non-linear associations using flexible functional 
forms ( quadratic splines with one inflection point around the median, i.e. at 70 years for the 
age at diagnosis, and at 0.1 for the deprivation score); from the original PS14 coded according 
to the World Health Organisation classification (indicating a person’s status relating to 
activity/disability), we re-coded this variable in 2 groups: good (0 or 1) vs. poor (2, 3 and 4); the 
4-category variable for stage at diagnosis was dichotomised in 2 groups: early stage (stage 1 
and 2) vs. late stage (3 and 4). It would be expected that patients with good PS and early tumour 
stage would be offered surgery as the first-choice treatment. Finally, we assumed an interaction 
between all the variables and the binary indicator defining early vs. late stage.  
To deal with the issue of missing data, we performed multiple imputation (MI) using the 
“Substantive-Model Compatible Fully Conditional Specification” (SMC-FCS) method,23 under 
the Missing At Random assumption24 (meaning that the probability of missing data in the 
particular covariate is dependent on the observed data, i.e. the other covariates and the 
outcome, but not additionally on the unobserved value of the particular covariate). The 
variables PET-CT scan, stage and PS had missing information, up to 30% of missing values for 
the PET-CT scan variable. These 3 variables being binary, we used a logistic regression model 
for the imputation including as variables all the prognostic factors defining the linear predictor 
(see above) in addition to the outcome (i.e. the binary surgery variable for Analysis 1 or the time 
and the type of event for Analysis 2). We generated 30 imputed datasets.25 
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To assess the strength of the association between the outcome and the deprivation score, we 
performed a Likelihood Ratio Test (LRT) on each imputed dataset by comparing a model that 
included the deprivation score (in its non-linear form and with the interaction) with one that 
did not. Each of the 30 LRT statistics were compared to a chi square distribution with 6 degrees 
of freedom. We also used a joint Wald test from the estimated parameters obtained after MI 
to assess the strength of the association between the outcome (either binary or time-to-event) 
and the deprivation score. 
We repeated the steps detailed above on the complete case data (using only the data from 
patients having no missing information in any of the variables), which is usually called a 
“sensitivity analysis”; it allows to assess how variables the results are to the missing data 
mechanism assumed, and thus how much caution may be needed in interpreting them.26 
 
RESULTS 
Study population 
The study population were 31351 patients diagnosed with NSCLC in England in 2012 (11030 
adenocarcinomas -35%-, 3442 large cells -11%-, 7058 squamous cells -23%- and 9821 other 
histological subtypes -31%-). The percentage of successful linkage between the cancer registry 
data (the core data) and the NLCA data was 83%, and it was higher than 99% for linkage with 
the HES data. From these patients, 4850 received surgery (Table 1). The mean age was 72.8 
years overall, the group who received surgery were younger on average (68.4 compared to 73.6 
years). Sixty eight percent of NSCLC were diagnosed with an advanced stage, 9% stage being 
missing. Information of PET-CT scan and performance status was also missing for 30% and 24% 
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of patients, respectively. COPD was the most prevalent co-morbidity (22%) with much lower 
prevalence observed for all other comorbidities (between 5.2% and 6.4%).  
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Table 1: Characteristics of patients diagnosed with Non-Small Cell Lung Cancer in England in 
2012 
 No Surgery Surgery p
a Total 
N N=26501 N=4850  N=31351 
Age at diagnosis (mean (sd)) 73.62 (10.89) 68.42 (9.81) <0.001 72.81 (10.90) 
Deprivation score (mean (sd)) 0.17 (0.11) 0.16 (0.12) 0.016 0.17 (0.12) 
Sex (%)     
Men 14729 (55.6) 2463 (50.8) <0.001 17192 (54.8) 
Women 11772 (44.4) 2387 (49.2)  14159 (45.2) 
PET-CT scan (%)     
No 12334 (46.5) 391 (8.1) <0.001 12725 (40.6) 
Yes 5428 (20.5) 3801 (78.4)  9229 (29.4) 
Missing 8739 (33.0) 658 (13.6)  9397 (30.0) 
Stage at diagnosis (%)     
Stage I-II (Early stage) 3339 (12.6) 3823 (78.8) <0.001 7162 (22.8) 
Stage III-IV (Advanced stage) 20488 (77.3) 878 (18.1)  21366 (68.2) 
Missing 2674 (10.1) 149 (3.1)  2823 (9.0) 
PS (%)     
Good (0 or 1) 9332 (35.2) 3728 (76.9) <0.001 13060 (41.7) 
Poor (2, 3 or 4) 10309 (38.9) 340 (7.0)  10649 (34.0) 
Missing 6860 (25.9) 782 (16.1)  7642 (24.4) 
Myocardial Infarction (%)     
No 25027 (94.4) 4633 (95.5) 0.002 29660 (94.6) 
Yes 1474 (5.6) 217 (4.5)  1691 (5.4) 
Congestive Heart Failure  (%)     
No 24955 (94.2) 4753 (98.0) <0.001 29708 (94.8) 
Yes 1546 (5.8) 97 (2.0)  1643 (5.2) 
Peripheral Vascular Disease (%)     
No 24771 (93.5) 4574 (94.3) 0.031 29345 (93.6) 
Yes 1730 (6.5) 276 (5.7)  2006 (6.4) 
Cerebrovascular disease (%)     
No 24726 (93.3) 4704 (97.0) <0.001 29430 (93.9) 
Yes 1775 (6.7) 146 (3.0)  1921 (6.1) 
COPD (%)     
No 20671 (78.0) 3949 (81.4) <0.001 24620 (78.5) 
Yes 5830 (22.0) 901 (18.6)  6731 (21.5) 
a: p-value of the test comparing the groups with and without surgery (t-test for continuous 
covariables and Chi2 test for categorical covariables) 
PS: Performance Score; COPD: Chronic Obstructive Pulmonary Disease 
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Results from Analysis 1: the multivariable logistic regression 
The strongest predictor of the odds of receiving surgery was stage: the adjusted odds of 
receiving surgery for advanced stage patients was 0.01 times that of early stage patients (OR: 
0.01, with 95% confidence interval [0.007;0.014]) (Table 2). This was expected because surgery 
is rarely offered to advanced stage patients. However, it indicates evidence of the quality and 
the validity of the dataset. Interactions between binary stage (early/advanced) and all other 
factors included in the logistic model enabled the parameter estimates for early and advanced 
stage to be interpreted separately, and we focus on interpreting the results among early stage 
patients unless otherwise stated. A poor performance status (2, 3 or 4) dramatically reduced 
the odds of receiving surgery (OR: 0.15 [0.13;0.17]. A recorded diagnosis of congestive heart 
failure, cerebrovascular disease or COPD was strongly associated with reduced odds of receiving 
surgery (ORs 0.55 [0.40;0.74], 0.58 [0.45;0.76] and 0.50 [0.43;0.57], respectively). By contrast, 
having had a PET-CT scan was associated with an increased odds of receiving surgery (3.65 
[3.08;4.33]). Women had higher odds of having surgery compared to men (OR 1.22 [1.08;1.38]).  
The probability to receive surgery for both early and advanced stage patients without any 
comorbidities, with good PS and who had a PET-CT scan performed is provided for men with 
low deprivation (score of 0.1) by age at diagnosis (Figure 1a). We observed a clear association 
between a patients’ age and the probability of receiving surgery with a dramatic decrease after 
75 years: the probability to receive surgery for a patient aged 50 years was 87.9% [85.4;90.0] 
compared to 65.2% [61.9;68.3] at 80 years (Figure 1a).  
The probability to receive surgery for both early and advanced stage patients aged 70 years at 
diagnosis by deprivation score is provided for men (Figure 1b).The joint Wald test showed 
evidence of differences on the probability to receive surgery by deprivation (p-value<0.01 of 
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the Chi2 test comparing models with and without deprivation score). This was also confirmed 
by the 30 LRT, all showing strong association between surgery and deprivation score. Overall, 
we observed decreasing probability of surgery from least to most deprived patients in early-
stage patients (figure 1b): the probability to receive surgery was 86.0% [83.1;88.4] for patients 
living in areas with 3% of people with low income (i.e. deprivation score of 0.03, less deprived) 
compared to 78.6% [75.7;81.3] for patients living in areas with 40% of people with low income 
(i.e. a deprivation score of 0.4, more deprived). Such difference was not observed in advanced-
stage patients for whom the probability to receive surgery was estimated around 16% for all 
deprivation scores, Figure 1b.  
The multivariable regression model does not include interactions between sex and age at 
diagnosis nor between sex and deprivation score. This leads to patterns of predicted 
probabilities of surgery for women similar to men, while at a different absolute level, by age 
and deprivation; we reported the predicted probability to receive surgery for both early and 
advanced stage patients without any comorbidities, with good PS and who had a PET-CT scan 
performed for women with a deprivation score of 0.1 according to age at diagnosis (Figure S1a, 
Appendix 1), and for women of 70 years old at diagnosis according to deprivation score (Figure 
S1b, Appendix 1). 
Comparing the results to those obtained with the complete case analysis, we observed a similar 
overall pattern of results, with slight differences in some point estimates (Table 2). These 
differences were expected as when we explored the missing data mechanism, we found that 
the probability of missing data for PS and for PET-CT scan was strongly associated with the 
outcome variable after controlling for other covariables. Such an observation of the missing 
data mechanism implied that the analysis based on complete cases would be expected to be 
biased.24   
16 
 
Table 2: Adjusteda odds ratios of receiving surgery with corresponding 95% Confidence Intervals 
(CI) within each stage-specific stratumb, and estimated i) after multiple imputation and ii) only 
using complete cases. 
 
 Multiple Imputation Complete Cases 
 OR 95% CI OR 95% CI 
In stratum with Early stage       
Sex (ref: Males) 1.22 1.08 1.38 1.18 1.03 1.35 
PET-CT scan (ref: No PET-CT Scan) 3.65 3.08 4.33 4.2 3.47 5.08 
PS (Ref PS=good) 0.15 0.13 0.17 0.16 0.13 0.18 
Myocardial Infarction (ref: No) 0.94 0.73 1.21 0.91 0.68 1.21 
Congestive Heart Failure (ref: No) 0.55 0.4 0.74 0.63 0.45 0.9 
Peripheral Vascular Disease (ref: No) 0.91 0.73 1.14 0.9 0.7 1.15 
Cerebrovascular disease (ref: No) 0.58 0.45 0.76 0.61 0.46 0.82 
COPD (ref: No) 0.5 0.43 0.57 0.49 0.42 0.57 
In stratum with Advanced stage       
Sex (ref: Males) 1.26 1.09 1.46 1.23 1.05 1.45 
PET-CT scan (ref: No PET-CT Scan) 14.53 11.53 18.3 16.64 13.21 20.97 
PS (Ref PS=good) 0.2 0.15 0.26 0.21 0.16 0.27 
Myocardial Infarction (ref: No) 1.18 0.81 1.74 1.07 0.73 1.58 
Congestive Heart Failure (ref: No) 0.55 0.31 0.99 0.47 0.26 0.86 
Peripheral Vascular Disease (ref: No) 1.04 0.73 1.48 0.92 0.65 1.32 
Cerebrovascular disease (ref: No) 0.65 0.39 1.08 0.82 0.49 1.37 
COPD (ref: No) 1.11 0.9 1.36 1.09 0.89 1.34 
a: the odds ratios are adjusted on the covariables reported in the table and also on age at 
diagnosis and deprivation score, those variables being modelled using a non-linear functional 
form (see methods section), and both with a main effect in addition to an interaction with the 
indicator variable “advanced stage”. 
b: the adjusted OR of receiving surgery for advanced stage patients compared to early stage 
patients was 0.01, 95% CI [0.007;0.014] after multiple imputation (OR=0.01 [0.008;0.016] for 
the complete cases). 
PS: Performance Score; COPD: Chronic Obstructive Pulmonary Disease 
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Results of Analysis 2: competing risks analysis 
The competing risk analysis corroborated the results obtained with the multivariable logistic 
regression, with a low Hazard Ratio (HR) of receiving surgery for all advanced stage patients and 
for patients with poor performance status in both early and advanced stage of diagnosis (Table 
3). The estimated HRs associated with comorbidities also showed strong evidence of a lower 
rate of receiving surgery for patients with congestive heart failure, cerebrovascular disease and 
COPD in early-stage patients. The mortality rate was clearly associated with stage: advanced 
stage patients had a mortality rate 3.34 [2.60;4.27] times higher than patients with an early 
stage diagnosis. A poor performance status increased the mortality rate in both early and 
advanced stage patients. None of the comorbid conditions showed any strong association with 
mortality.  
The rate of receiving surgery decreased dramatically for older patients (Figure 2a): early-stage 
patient aged 80 years at diagnosis had around half the rate of receiving surgery of early stage 
patients aged 70 years (HR 0.57 [0.54;0.60]). Furthermore, we found strong evidence of an 
association between the rate of receiving surgery and deprivation score from both the joint 
Wald test and the 30 LR Tests. The rate of receiving surgery for an early stage deprived patient 
(deprivation score of 0.4) was 12% lower than that of a less deprived patient (deprivation score 
of 0.1, HR 0.88 [0.80;0.97]) (Figure 2b). We observed a clear association with age for both stage 
groups (Figure 3a), but no association with deprivation score (Figure 3b) on the hazard of death 
without surgery. From the complete case analysis, we reported similar patterns with slight 
differences in some point estimates (Table 3). 
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Table 3: Adjusteda hazard ratios of receiving surgery and of death with corresponding 95% Confidence Intervals (CI) within each stage-specific 
stratumb, and estimated i) after multiple imputation and ii) only using complete cases. 
 Multiple Imputation  Complete Cases 
 Surgery Death  Surgery Death 
 HR 95% CI HR 95% CI 
 HR 95% CI HR 95% CI 
In stratum with Early stage              
Sex (ref: Males) 1.14 1.07 1.22 0.79 0.69 0.91  1.13 1.05 1.21 0.79 0.66 0.93 
PET-CT scan (ref: No PET-CT Scan) 2.03 1.78 2.31 0.32 0.27 0.4  2.27 1.98 2.61 0.31 0.25 0.37 
PS (Ref PS=good) 0.25 0.22 0.29 2.36 1.93 2.89  0.27 0.24 0.31 2.45 1.98 3.03 
Myocardial Infarction (ref: No) 0.96 0.82 1.13 0.96 0.76 1.23  0.93 0.78 1.1 0.82 0.6 1.14 
Congestive Heart Failure (ref: No) 0.61 0.49 0.77 1.14 0.92 1.42  0.66 0.51 0.85 1.06 0.79 1.4 
Peripheral Vascular Disease (ref: No) 0.94 0.81 1.08 1.05 0.84 1.32  0.94 0.81 1.09 1.04 0.78 1.38 
Cerebrovascular disease (ref: No) 0.73 0.61 0.88 1.01 0.81 1.27  0.76 0.63 0.93 1.05 0.79 1.39 
COPD (ref: No) 0.71 0.65 0.77 1.06 0.92 1.24  0.71 0.65 0.78 1.1 0.91 1.32 
In stratum with Advanced stage              
Sex (ref: Males) 1.22 1.07 1.39 0.88 0.85 0.91  1.21 1.04 1.4 0.88 0.84 0.92 
PET-CT scan (ref: No PET-CT Scan) 12.02 9.58 15.09 0.33 0.31 0.36  13.49 10.48 17.37 0.33 0.3 0.35 
PS (Ref PS=good) 0.23 0.17 0.3 2.7 2.58 2.83  0.25 0.18 0.33 2.77 2.63 2.91 
Myocardial Infarction (ref: No) 1.12 0.78 1.6 1.05 0.97 1.13  1.03 0.69 1.53 1.04 0.93 1.15 
Congestive Heart Failure (ref: No) 0.59 0.34 1.03 0.99 0.92 1.07  0.49 0.25 0.97 1 0.9 1.11 
Peripheral Vascular Disease (ref: No) 1.03 0.74 1.44 1.07 1 1.15  0.93 0.64 1.37 1.09 1 1.2 
Cerebrovascular disease (ref: No) 0.68 0.42 1.11 0.96 0.9 1.03  0.84 0.5 1.4 0.96 0.87 1.05 
COPD (ref: No) 1.1 0.91 1.33 0.94 0.9 0.99  1.08 0.88 1.33 0.95 0.9 1.01 
a: the rate ratios are adjusted on the covariables reported in the table and also on age at diagnosis and deprivation score, those variables being 
modelled using a non-linear functional form (see methods section), and both with a main effect in addition to an interaction with the indicator 
variable “advanced stage”. 
b: the adjusted HR of receiving surgery for advanced stage patients compared to early stage patients was 0.02, 95% CI [0.01;0.03] after multiple 
imputation (HR=0.02 [0.01;0.03] for the complete cases), and adjusted HR of death for advanced stage patients compared to early stage patients 
was 3.34 [2.60;4.27] after multiple imputation (HR=3.32 [2.51;4.38] for the complete cases). 
PS: Performance Score; COPD: Chronic Obstructive Pulmonary Disease 
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DISCUSSION 
This study found strong evidence of an inverse association between the receipt of surgery and 
the comorbidities congestive heart failure, cerebrovascular disease and COPD in patients with 
early stage. We also observed an important fall in the receipt of surgery with increasing age at 
diagnosis. Despite adjusting for these prognostic factors, the receipt of surgery still also 
depended upon the deprivation score: more deprived patients have a lower probability of 
receiving surgical treatment compared to less deprived patients. Stage at diagnosis and the 
patient’s performance status were confirmed as the strongest predictors for receiving major 
surgery while there was a clear association between having had a PET-CT scan and the receipt 
of major surgery.  
One major strength of the study is the use of population-based cancer registry data linked to 
NLCA data and HES data, which provided an enriched source of information describing the 
probability to receive surgery among NSCLC patients diagnosed in England in 2012. We focused 
on NSCLC patients as surgery is the recommended treatment in contrast to small-cell lung 
carcinomas where the primary treatment is usually chemotherapy. We benefitted from 
algorithms that made the best use of our data,16 17 and enabled information on stage at 
diagnosis and specific type of comorbidities to be included as predictors for the probability to 
receive surgery. We assumed that the measurement of detailed information on important 
prognostic factors such as comorbidities, stage, PET-CT scan and PS were either properly 
recorded (i.e. no measurement error nor misclassification) or properly retrieved using the 
developed algorithms. We analysed an area-based measure for deprivation;21 it has the 
advantage of encapsulating both the individual SES and the greater environment where the 
patient lives.27 
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The study dealt with the problem of missing data using a MI technique which properly accounts 
for the presence of non-linear functional forms for the continuous variable, as well as 
interactions between variables.23 This is another strength of this work as we found other studies 
that either discarded missing data28 29 or treated them as another category,10 11 30 although 
neither of these approaches are recommended. As we were expecting a strong association 
between stage at diagnosis and the outcome, we assumed an interaction between stage and 
all the other prognostic factors, which was particularly insightful for interpreting results among 
early-stage lung cancer. We analysed continuous variables (age and deprivation score) in their 
existing form, allowing the depiction of their continuous gradual association with the receipt of 
surgery through flexible functional forms (such as splines, as used here). Under the assumption 
of the Missing At Random missingness mechanism, results from the multiple imputation are 
unbiased.24   
In the multivariable logistic regression, the outcome was receiving surgery yes/no. The group 
of patients who did not receive surgery within the first 6 months following diagnosis are a 
mixture of (i) patients who were alive and not surgically treated and (ii) patients who died during 
the first 6 months without receiving surgery. This last group being not “at risk” of receiving 
surgery complicates the interpretation.31 The competing risk analysis allowed us to distinguish 
the two different event types (surgery or death), whichever came first.22 In both analyses, we 
used a model parametrisation that allows for interpretation of the parameter estimates for the 
early and the advanced stage groups separately, due to the interaction between 
early/advanced stage and all the other variables. The results from both analyses led to the same 
findings, which were consistent with results previously published. Firstly, the stage at diagnosis 
was the strongest predictor of receiving surgery.10 The patient’s PS and the indication of a PET-
CT scan performed32 were also strongly associated with surgery. The persisting differences 
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observed between the less and more deprived patients in their receipt of major surgery was 
also found in some other studies,8 11 33-36 with the exception of Rich et al.30 However, in this 
latter study, the authors dealt with the missing data problem differently from us, as they 
created an additional category “missing”, which may lead to biased estimation.37 38 We also 
observed an important decrease in the probability to receive surgery in older patients,39 40 even 
if their benefit in receiving surgical treatment was equivalent to that of their younger 
counterparts.41 Indeed, as stressed by Chambers et al.41 “several prospective and large 
population studies have shown unanimously, that patients >70 years of age respond as well as 
younger patients in all outcome measures pertaining to morbidity, mortality and QoL [Quality 
of Life] postoperatively, and should receive aggressive surgical management if considered fit for 
surgery, in accordance with the British Thoracic Society guidelines.” 
We showed strong evidence of lower odds of having major surgery in patients with Congestive 
Heart Failure, Cerebrovascular disease and COPD in patients with early stage, consistently with 
a population-based study conducted in the United States,29 while another study conducted in 
the Netherlands did not find an association between comorbidity conditions and treatment 
received for NSCLC patients.40 However, a limitation of the study is related to the information 
used for comorbidity, which is derived from the HES datasets.17 Thus we do not know the 
comorbidity status for patients who never attended secondary care, and assume they do not 
have any comorbidities. This could also be the case in an instance where comorbid patients 
attend hospital, but their comorbidities are erroneously not disclosed in hospital records. So, 
our measure of comorbidity-specific conditions could underestimate the level of comorbidity 
at a population level. However, we focused on the more severe comorbidities that are likely to 
limit fitness for surgery and thus, we would expect the majority of patients with these more 
serious ‘grades’ of illnesses to have been admitted to hospital at some stage. Having had a PET-
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CT scan could be considered as a possible mediator (thus being on the causal pathway) between 
deprivation and receipt of surgery and between comorbidities and receipt of surgery. We 
therefore performed a supplementary sensitivity analysis (using a competing-risks method of 
analysis and focusing on the receipt of surgery, see method) without adjusting on the PET-CT 
scan variable to evaluate the consistency of the results. The adjusted hazard ratios of receiving 
surgery were quite similar to those presented in Table 3 and in Figure 2, and the main 
conclusions remained unchanged (data not shown). Those additional results suggest that 
having had a PET-CT scan performed played a minor role on the socioeconomic differences to 
receive surgery. 
It appears that further investigation is warranted to understand why the more deprived patients 
have a lower probability of receiving surgery compared with the less deprived patients, and also 
why there is an extremely large gradient in receiving surgery according to the age at diagnosis. 
An approach would be to describe the patient choice, as this is always a major factor in whether 
treatment, especially surgical treatment, is carried out.  It may well be that older and more 
deprived patients are less likely to agree to surgical treatment. Perceptions of treatments, 
wishes, levels of engagement with healthcare and understanding of risks of benefits of surgery 
- all of which affect patient choice - may vary by socio-economic level. Travel issues (e.g. costs 
and time to travel) may well also come into play in these groups of patients. A study conducted 
in Australia showed that the longer the distance to a specialist hospital the lower the chance of 
receiving surgery.42 A comparable investigation would be to assess urban-rural difference in 
access to treatment and receipt of surgery, as reported in the US and in Ireland,28 43 as well as 
whether a patient was first seen at a thoracic surgical centre.30 Crawford et al. showed distance 
from surgical centre and socio-economic deprivation were additive in their association with 
lower resection rates in a study from Yorkshire in the UK.35 Therefore, an interesting step 
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forward would be to describe patient choice according to the main patient characteristics 
(including age and deprivation level). This could be informative in identifying key learning 
points, such as highlighting the need to focus on either improving access to tertiary services, 
providing clear information to help inform patient choice and evaluating financial barriers to 
undergoing surgery (e.g. transport costs/leave from work). 
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Figure legends 
 
Figure 1: Predicted probability of receiving major surgery with 95% confidence interval for early 
stage (solid line) and advanced stage (dashed line) in male NSCLC patients without any 
comorbidities, with good performance status, having had a PET-CT scan: (a) according to age at 
diagnosis with a deprivation score of 0.1 or (b) according to deprivation score with an age at 
diagnosis of 70 years. Results are based on the multivariable logistic regression. The ranges of 
age at diagnosis and deprivation score were limited to the 2.5th and 97.5th percentile of the 
observed distribution. 
 
Figure 2: Adjusted Hazard ratio of receiving major surgery with 95% confidence interval for early 
stage (solid line) and advanced stage (dashed line) in male NSCLC patients without any 
comorbidities, with good performance status, having had a PET-CT scan: (a) according to age at 
diagnosis with a deprivation score of 0.1 or (b) according to deprivation score with an age at 
diagnosis of 70 years. Results are based on the competing risks analysis using semi-parametric 
Cox models. The ranges of age at diagnosis and deprivation score were limited to the 2.5th and 
97.5th percentile of the observed distribution. 
 
Figure 3: Adjusted Hazard ratio of death with 95% confidence interval for early stage (solid line) 
and advanced stage (dashed line) in male NSCLC patients without any comorbidities, with good 
performance status, having had a PET-CT scan: (a) according to age at diagnosis with a 
deprivation score of 0.1 or (b) according to deprivation score with an age at diagnosis of 70 
years. Results are based on the competing risks analysis using semi-parametric Cox models The 
ranges of age at diagnosis and deprivation score were limited to the 2.5th and 97.5th percentile 
of the observed distribution. 
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Table S1: OPCS-4 codes used to identify a major surgical procedure (National Cancer 
Intelligence Network) 
 
Code  Description  Number identified in 2012 in 
England in NSCLC patients  
E391  Open excision of lesion of trachea  5 
E398  Other specified partial excision of trachea  0 
E399  Unspecified partial excision of trachea  0 
E441  Excision of carina  2 
E461  Sleeve resection of bronchus and 
anastomosis HFQ  
9 
E541  Total pneumonectomy, total removal of 
lung, Pneumonectomy NEC  
292 
E542  Bilobectomy of lung  141 
E543  Lobectomy of lung  3384 
E544  Excision of segment of lung  816 
E545  Partial lobectomy of lung NEC  75 
E548  Excision of lung, other specified  75 
E549  Excision of lung, Unspecified  1 
E552  Open excision of lesion of lung  40 
E559  Open removal of lesion of lung, unspecified  0 
T013  Excision of lesion of chest wall  10 
T023  Insertion of prothesis into chest wall NEC 0 
 
  
Figure S1: Predicted probability of receiving major surgery with 95% confidence interval for 
early stage (solid line) and advanced stage (dashed line) in female NSCLC patients without any 
comorbidities, with good performance status, having had a PET-CT scan: (a) according to age 
at diagnosis with a deprivation score of 0.1 or (b) according to deprivation score with an age 
at diagnosis of 70 years. Results are based on the multivariable logistic regression. The ranges 
of age at diagnosis and deprivation score were limited to the 2.5th and 97.5th percentile of 
the observed distribution. 
 
 
 
Figure S2: Distribution of the Income Domain score among NSCLC patients diagnosed in 2012 
in England (mean=0.17, 1st quartile=0.07, 3rd quartile=0.23) 
 



